Rose-EV Intimate-Care Line — Documented Comfort for Beauty's Most Sensitive Shelf

The problem this playbook solves: intimate care is the most sensitive shelf in beauty — products are either clinical and cold or herbal and undocumented, with nothing gentle and documented between.

01 · The problem

Intimate care concentrates every wellness difficulty into one purchase: the highest sensitivity to wording, the lowest tolerance for overclaim, ingredient scrutiny at its most careful — and a shelf that offers either medical-register products or herbal formulas with no documentation. A gentle, documented, rose-EV daily comfort line is the missing middle.

02 · Scientific rationale

Three design decisions define the category's safe-and-credible position: rose-derived plant EV fractions (a plant-origin story with cosmetics-friendly registration history), a soft-care base (fragrance-minimal, physiologic-pH mindset), and documentation depth (batch COA, characterization baseline) presented openly. Grand Ingredients' trend work notes plant EV carriers as one of the few active classes with both novelty and a compliant phrasing path [4].

03 · Program documentation

Rose-derived plant EV platform documentation is maintained internally (extraction, characterization baseline) [7]; intimate-care formulas add physiologic-pH and sensory panel records. The evidence hierarchy matches every TONGNIAN program: published reviews first, internal observational programs second, case documentation third.

Method anchors: [1] EV biology and cargo [2] MISEV2018 characterization [3] category evidence (review or registered study) [4] formulation and handling guidance [5] national measurement guideline (2026 No. 17) [6] internal protocol and case documentation.

04 · Product architecture

05 · Process & QC

EV material runs on the fully enclosed 0.5–5 L micro-batch line with low-shear handling qualified at process validation [4]. QC panel design follows MISEV2018 [2] and the national measurement guideline (2026 No. 17; TONGNIAN is a drafting organization) [5].

Fig. 1 — The intimate-care line map: core, travel, pairing.

06 · Regulatory pathway: EU & US first

EU: Regulation (EC) No 1223/2009 — CPNP notification, Responsible Person, PIF/CPSR. US: MoCRA (2022) registration and listing; INCI labelling (41316). Appearance-level claims only per EU Reg. 655/2013 and US advertising standards. China market entry later maps to the CSAR track — additional market. Additional category discipline: intimate-care wording stays at comfort and freshness level; no health claims of any kind.

07 · Expected outcomes

• Trust-first shelf position: the COA and batch record on the shelf do the converting.
• Soft-care formulation designed for the most wording-sensitive category in beauty.
• Line economics: mist + travel + pairing covers the ritual without SKU bloat.

No claims are made beyond the destination-market framing — authority comes from documentation and batch measurement.

08 · Commercial framework

Sample kits in 3–5 days; pilot from 500 units; production from 2,000 units; standard lead 15 workdays — all indicative, quoted per request. White-label runs through the OBM program.

Request a quote · Line fact-sheet

References

1. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
2. Grand Ingredients. Exosome-Mimetic Systems 2026; cargo-handling reference.
3. TONGNIAN. Rose-derived plant EV platform documentation (internal).
4. Guideline for Exosome Particle Size and Concentration Measurement (2026 No. 17) — TONGNIAN, drafting organization.
5. TONGNIAN network clinics. Anonymized internal protocol and case documentation (partner access under NDA).